Patients Beyond distance and stigma: AI's potential to democratise he... Access to healthcare and health information remains vastly unequal, fuelled by factors like wealth, geography, language, and literacy.
News ASCO 25: J&J combo pill may see wider use in prostate cancer AMPLITUDE study of J&J's Akeega could extend the use of PARP inhibitors to hormone-responsive prostate cancer.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.